Control of diabetic hyperglycaemia and insulin resistance through TSC22D4

TSC22D4 regulates hepatic lipoprotein production, but has so far mainly been studied in the context of cancer cachexia. Here, the authors show TSC22D4 inhibition improves insulin sensitivity in several mouse models of diabetes, which they attribute at least in part to the induction of secreted LCN13...

Full description

Bibliographic Details
Main Authors: Bilgen Ekim Üstünel, Kilian Friedrich, Adriano Maida, Xiaoyue Wang, Anja Krones-Herzig, Oksana Seibert, Anke Sommerfeld, Allan Jones, Tjeerd P. Sijmonsma, Carsten Sticht, Norbert Gretz, Thomas Fleming, Peter P. Nawroth, Wolfgang Stremmel, Adam J. Rose, Mauricio Berriel-Diaz, Matthias Blüher, Stephan Herzig
Format: Article
Language:English
Published: Nature Portfolio 2016-11-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/ncomms13267
_version_ 1818956984996593664
author Bilgen Ekim Üstünel
Kilian Friedrich
Adriano Maida
Xiaoyue Wang
Anja Krones-Herzig
Oksana Seibert
Anke Sommerfeld
Allan Jones
Tjeerd P. Sijmonsma
Carsten Sticht
Norbert Gretz
Thomas Fleming
Peter P. Nawroth
Wolfgang Stremmel
Adam J. Rose
Mauricio Berriel-Diaz
Matthias Blüher
Stephan Herzig
author_facet Bilgen Ekim Üstünel
Kilian Friedrich
Adriano Maida
Xiaoyue Wang
Anja Krones-Herzig
Oksana Seibert
Anke Sommerfeld
Allan Jones
Tjeerd P. Sijmonsma
Carsten Sticht
Norbert Gretz
Thomas Fleming
Peter P. Nawroth
Wolfgang Stremmel
Adam J. Rose
Mauricio Berriel-Diaz
Matthias Blüher
Stephan Herzig
author_sort Bilgen Ekim Üstünel
collection DOAJ
description TSC22D4 regulates hepatic lipoprotein production, but has so far mainly been studied in the context of cancer cachexia. Here, the authors show TSC22D4 inhibition improves insulin sensitivity in several mouse models of diabetes, which they attribute at least in part to the induction of secreted LCN13.
first_indexed 2024-12-20T11:02:39Z
format Article
id doaj.art-6fbad84b0b124d8487619a25d73053a2
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-20T11:02:39Z
publishDate 2016-11-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-6fbad84b0b124d8487619a25d73053a22022-12-21T19:42:58ZengNature PortfolioNature Communications2041-17232016-11-017111110.1038/ncomms13267Control of diabetic hyperglycaemia and insulin resistance through TSC22D4Bilgen Ekim Üstünel0Kilian Friedrich1Adriano Maida2Xiaoyue Wang3Anja Krones-Herzig4Oksana Seibert5Anke Sommerfeld6Allan Jones7Tjeerd P. Sijmonsma8Carsten Sticht9Norbert Gretz10Thomas Fleming11Peter P. Nawroth12Wolfgang Stremmel13Adam J. Rose14Mauricio Berriel-Diaz15Matthias Blüher16Stephan Herzig17Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramCenter for Clinical Research, Medical Faculty MannheimCenter for Clinical Research, Medical Faculty MannheimDepartment of Medicine I and Clinical Chemistry, Heidelberg UniversityDepartment of Medicine I and Clinical Chemistry, Heidelberg UniversityDepartment of Internal Medicine IV, Heidelberg University HospitalInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramDepartment of Medicine, University of LeipzigInstitute for Diabetes and Cancer (IDC), Helmholtz Center Munich, and Joint Heidelberg-IDC Translational Diabetes ProgramTSC22D4 regulates hepatic lipoprotein production, but has so far mainly been studied in the context of cancer cachexia. Here, the authors show TSC22D4 inhibition improves insulin sensitivity in several mouse models of diabetes, which they attribute at least in part to the induction of secreted LCN13.https://doi.org/10.1038/ncomms13267
spellingShingle Bilgen Ekim Üstünel
Kilian Friedrich
Adriano Maida
Xiaoyue Wang
Anja Krones-Herzig
Oksana Seibert
Anke Sommerfeld
Allan Jones
Tjeerd P. Sijmonsma
Carsten Sticht
Norbert Gretz
Thomas Fleming
Peter P. Nawroth
Wolfgang Stremmel
Adam J. Rose
Mauricio Berriel-Diaz
Matthias Blüher
Stephan Herzig
Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
Nature Communications
title Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
title_full Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
title_fullStr Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
title_full_unstemmed Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
title_short Control of diabetic hyperglycaemia and insulin resistance through TSC22D4
title_sort control of diabetic hyperglycaemia and insulin resistance through tsc22d4
url https://doi.org/10.1038/ncomms13267
work_keys_str_mv AT bilgenekimustunel controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT kilianfriedrich controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT adrianomaida controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT xiaoyuewang controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT anjakronesherzig controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT oksanaseibert controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT ankesommerfeld controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT allanjones controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT tjeerdpsijmonsma controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT carstensticht controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT norbertgretz controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT thomasfleming controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT peterpnawroth controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT wolfgangstremmel controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT adamjrose controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT mauricioberrieldiaz controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT matthiasbluher controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4
AT stephanherzig controlofdiabetichyperglycaemiaandinsulinresistancethroughtsc22d4